237 related articles for article (PubMed ID: 28321548)
1. Demethylating agent decitabine disrupts tumor-induced immune tolerance by depleting myeloid-derived suppressor cells.
Zhou J; Yao Y; Shen Q; Li G; Hu L; Zhang X
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1371-1380. PubMed ID: 28321548
[TBL] [Abstract][Full Text] [Related]
2. Decitabine shows potent anti-myeloma activity by depleting monocytic myeloid-derived suppressor cells in the myeloma microenvironment.
Zhou J; Shen Q; Lin H; Hu L; Li G; Zhang X
J Cancer Res Clin Oncol; 2019 Feb; 145(2):329-336. PubMed ID: 30426212
[TBL] [Abstract][Full Text] [Related]
3. Oxaliplatin regulates myeloid-derived suppressor cell-mediated immunosuppression via downregulation of nuclear factor-κB signaling.
Kim NR; Kim YJ
Cancer Med; 2019 Jan; 8(1):276-288. PubMed ID: 30592157
[TBL] [Abstract][Full Text] [Related]
4. Low dose decitabine treatment induces CD80 expression in cancer cells and stimulates tumor specific cytotoxic T lymphocyte responses.
Wang LX; Mei ZY; Zhou JH; Yao YS; Li YH; Xu YH; Li JX; Gao XN; Zhou MH; Jiang MM; Gao L; Ding Y; Lu XC; Shi JL; Luo XF; Wang J; Wang LL; Qu C; Bai XF; Yu L
PLoS One; 2013; 8(5):e62924. PubMed ID: 23671644
[TBL] [Abstract][Full Text] [Related]
5. The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer.
Luker AJ; Graham LJ; Smith TM; Camarena C; Zellner MP; Gilmer JS; Damle SR; Conrad DH; Bear HD; Martin RK
BMC Immunol; 2020 Feb; 21(1):8. PubMed ID: 32106810
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-derived suppressor cells in transplantation tolerance induction.
Cao P; Sun Z; Feng C; Zhang J; Zhang F; Wang W; Zhao Y
Int Immunopharmacol; 2020 Jun; 83():106421. PubMed ID: 32217462
[TBL] [Abstract][Full Text] [Related]
7. Adoptive transfer of IFN-γ-induced M-MDSCs promotes immune tolerance to allografts through iNOS pathway.
Yang F; Li Y; Zou W; Xu Y; Wang H; Wang W; Zhao Y
Inflamm Res; 2019 Jul; 68(7):545-555. PubMed ID: 31055608
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy.
Sun L; Clavijo PE; Robbins Y; Patel P; Friedman J; Greene S; Das R; Silvin C; Van Waes C; Horn LA; Schlom J; Palena C; Maeda D; Zebala J; Allen CT
JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30944253
[TBL] [Abstract][Full Text] [Related]
9. Decitabine suppresses MDSC-induced immunosuppression through dual functional mechanism and inhibits melanoma metastasis.
Zhang Z; Wang T; Fang G; Xiao X; Zhang Z; Zhao J
Med Oncol; 2024 May; 41(7):165. PubMed ID: 38819590
[TBL] [Abstract][Full Text] [Related]
10. Granulocytic myeloid-derived suppressor cells maintain feto-maternal tolerance by inducing Foxp3 expression in CD4+CD25-T cells by activation of the TGF-β/β-catenin pathway.
Kang X; Zhang X; Liu Z; Xu H; Wang T; He L; Zhao A
Mol Hum Reprod; 2016 Jul; 22(7):499-511. PubMed ID: 27016139
[TBL] [Abstract][Full Text] [Related]
11. DNA methyltransferase inhibition increases efficacy of adoptive cellular immunotherapy of murine breast cancer.
Terracina KP; Graham LJ; Payne KK; Manjili MH; Baek A; Damle SR; Bear HD
Cancer Immunol Immunother; 2016 Sep; 65(9):1061-73. PubMed ID: 27416831
[TBL] [Abstract][Full Text] [Related]
12. Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses.
Kontaki E; Boumpas DT; Tzardi M; Mouzas IA; Papadakis KA; Verginis P
Autoimmunity; 2017 May; 50(3):170-181. PubMed ID: 28276713
[TBL] [Abstract][Full Text] [Related]
13. Frontline Science: Myeloid-derived suppressor cells (MDSCs) facilitate maternal-fetal tolerance in mice.
Ostrand-Rosenberg S; Sinha P; Figley C; Long R; Park D; Carter D; Clements VK
J Leukoc Biol; 2017 May; 101(5):1091-1101. PubMed ID: 28007981
[TBL] [Abstract][Full Text] [Related]
14. Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the
Kobayashi M; Chung JS; Beg M; Arriaga Y; Verma U; Courtney K; Mansour J; Haley B; Khan S; Horiuchi Y; Ramani V; Harker D; Gopal P; Araghizadeh F; Cruz PD; Ariizumi K
Clin Cancer Res; 2019 Jan; 25(2):828-838. PubMed ID: 30049749
[TBL] [Abstract][Full Text] [Related]
15. TGF-β Enhances the Anti-inflammatory Effect of Tumor- Infiltrating CD33+11b+HLA-DR Myeloid-Derived Suppressor Cells in Gastric Cancer: A Possible Relation to MicroRNA-494.
Moaaz M; Lotfy H; Elsherbini B; Motawea MA; Fadali G
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3393-3403. PubMed ID: 33247701
[TBL] [Abstract][Full Text] [Related]
16. A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers.
Kodumudi KN; Woan K; Gilvary DL; Sahakian E; Wei S; Djeu JY
Clin Cancer Res; 2010 Sep; 16(18):4583-94. PubMed ID: 20702612
[TBL] [Abstract][Full Text] [Related]
17. Mathematical modeling of tumor-induced immunosuppression by myeloid-derived suppressor cells: Implications for therapeutic targeting strategies.
Shariatpanahi SP; Shariatpanahi SP; Madjidzadeh K; Hassan M; Abedi-Valugerdi M
J Theor Biol; 2018 Apr; 442():1-10. PubMed ID: 29337259
[TBL] [Abstract][Full Text] [Related]
18. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells.
Alissafi T; Hatzioannou A; Mintzas K; Barouni RM; Banos A; Sormendi S; Polyzos A; Xilouri M; Wielockx B; Gogas H; Verginis P
J Clin Invest; 2018 Aug; 128(9):3840-3852. PubMed ID: 29920188
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of low-dose decitabine on immune effector and suppressor responses in melanoma-bearing mice.
Triozzi PL; Aldrich W; Achberger S; Ponnazhagan S; Alcazar O; Saunthararajah Y
Cancer Immunol Immunother; 2012 Sep; 61(9):1441-50. PubMed ID: 22310929
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of LOX-1
Li X; Li JL; Jiang N; Chen J; Liang ZM; Zhao ZL; Xing YF
Aging (Albany NY); 2020 Dec; 13(1):437-449. PubMed ID: 33290259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
